ReP USP - Resultado da busca

Filtros : "Financiamento FAPESP" "NEOPLASIAS" "CUNHA, FERNANDO DE QUEIROZ" Limpar

Filtros

Artigo de periodico
Fast and furious: the neutrophil and its armamentarium in health and disease (2023)
Metzemaekers, Mieke; Malengier‐Devlies, Bert; Gouwy, Mieke; De Somer, Lien; Cunha, Fernando de Queiroz ; Opdenakker, Ghislain; Proost, Paul
Fonte: Medicinal Research Reviews. Unidade: FMRP
Assuntos: AUTOIMUNIDADE, INFLAMAÇÃO, NEUTRÓFILOS, ANTI-INFECCIOSOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
METZEMAEKERS, Mieke et al. Fast and furious: the neutrophil and its armamentarium in health and disease. Medicinal Research Reviews, v. 43, n. 5, p. 1537-1606, 2023Tradução . . Disponível em: https://doi.org/10.1002/med.21958. Acesso em: 08 out. 2025.
APA
Metzemaekers, M., Malengier‐Devlies, B., Gouwy, M., De Somer, L., Cunha, F. de Q., Opdenakker, G., & Proost, P. (2023). Fast and furious: the neutrophil and its armamentarium in health and disease. Medicinal Research Reviews, 43( 5), 1537-1606. doi:10.1002/med.21958
NLM
Metzemaekers M, Malengier‐Devlies B, Gouwy M, De Somer L, Cunha F de Q, Opdenakker G, Proost P. Fast and furious: the neutrophil and its armamentarium in health and disease [Internet]. Medicinal Research Reviews. 2023 ; 43( 5): 1537-1606.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/med.21958
Vancouver
Metzemaekers M, Malengier‐Devlies B, Gouwy M, De Somer L, Cunha F de Q, Opdenakker G, Proost P. Fast and furious: the neutrophil and its armamentarium in health and disease [Internet]. Medicinal Research Reviews. 2023 ; 43( 5): 1537-1606.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/med.21958
Artigo de periodico
Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications (2022)
Wanderley, Carlos Wagner de Souza ; Correa, Tatiana Strava; Scaranti, Mariana; Cunha, Fernando de Queiroz ; Barroso-Sousa, Romualdo
Fonte: Frontiers in Immunology. Unidade: FMRP
Assuntos: REPARAÇÃO DE DNA, IMUNOTERAPIA, NEOPLASIAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANDERLEY, Carlos Wagner de Souza et al. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.816642. Acesso em: 08 out. 2025.
APA
Wanderley, C. W. de S., Correa, T. S., Scaranti, M., Cunha, F. de Q., & Barroso-Sousa, R. (2022). Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.816642
NLM
Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fimmu.2022.816642
Vancouver
Wanderley CW de S, Correa TS, Scaranti M, Cunha F de Q, Barroso-Sousa R. Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fimmu.2022.816642

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2025